SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-427895
Filing Date
2013-11-05
Accepted
2013-11-05 17:02:55
Documents
10
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d601993d10q.htm 10-Q 501939
2 EX-31.1 d601993dex311.htm EX-31.1 8391
3 EX-31.2 d601993dex312.htm EX-31.2 8423
4 EX-32.1 d601993dex321.htm EX-32.1 5154
  Complete submission text file 0001193125-13-427895.txt   5114236

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT sgnt-20130930.xml EX-101.INS 670950
6 XBRL TAXONOMY EXTENSION SCHEMA sgnt-20130930.xsd EX-101.SCH 51348
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sgnt-20130930_cal.xml EX-101.CAL 82560
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sgnt-20130930_def.xml EX-101.DEF 335635
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE sgnt-20130930_lab.xml EX-101.LAB 390987
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sgnt-20130930_pre.xml EX-101.PRE 397025
Mailing Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195
Business Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195 847-908-1604
Sagent Pharmaceuticals, Inc. (Filer) CIK: 0001369786 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 10-Q | Act: 34 | File No.: 001-35144 | Film No.: 131193430
SIC: 2834 Pharmaceutical Preparations